Sengenics Launches ImmuSAFE COVID+, the World’s First High-Throughput, Multi-Antigen COVID-19 Biochip Test
SINGAPORE--(BUSINESS WIRE)--Sengenics, the Functional Proteomics Company, today announced the launch of ImmuSAFE™ COVID+, a multi-antigen, multi-domain, fully quantitative serology test....






